Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-06

Clinical Trial Update: PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating PRGF-ENDORET injections for low back pain; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRGF-ENDORET (platelet-rich growth factor therapy (PRGF-Endoret))

Snippet

Sponsor: Biotechnology Institute IMASD | Conditions: Diseases [C] - Musculoskeletal Diseases [C05 | Phase 4 | Status: RECRUITING